stoxline Quote Chart Rank Option Currency Glossary
  
89bio, Inc. (ETNB)
8.4  -0.46 (-5.19%)    06-18 16:00
Open: 8.84
High: 8.915
Volume: 665,880
  
Pre. Close: 8.86
Low: 8.34
Market Cap: 826(M)
Technical analysis
2024-06-18 4:45:43 PM
Short term     
Mid term     
Targets 6-month :  10.51 1-year :  11.63
Resists First :  9 Second :  9.96
Pivot price 8.4
Supports First :  7.44 Second :  6.19
MAs MA(5) :  8.95 MA(20) :  8.43
MA(100) :  9.92 MA(250) :  11.8
MACD MACD :  -0.1 Signal :  -0.2
%K %D K(14,3) :  48.8 D(3) :  59.4
RSI RSI(14): 45.9
52-week High :  20.28 Low :  6.57
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ETNB ] has closed above bottom band by 49.6%. Bollinger Bands are 23.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 8.93 - 8.97 8.97 - 9.01
Low: 8.22 - 8.27 8.27 - 8.32
Close: 8.3 - 8.39 8.39 - 8.47
Company Description

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.

Headline News

Sun, 16 Jun 2024
89bio (NASDAQ:ETNB) Shares Down 9.1% - Defense World

Sat, 15 Jun 2024
89bio, Inc. (NASDAQ:ETNB) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Sat, 15 Jun 2024
Orchard Capital Management LLC Purchases 196329 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World

Fri, 14 Jun 2024
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Fri, 14 Jun 2024
89bio (NASDAQ:ETNB) Trading Down 9.1% - MarketBeat

Fri, 07 Jun 2024
RTW Investments LP Acquires New Position in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 98 (M)
Shares Float 70 (M)
Held by Insiders 0.7 (%)
Held by Institutions 107 (%)
Shares Short 10,120 (K)
Shares Short P.Month 11,210 (K)
Stock Financials
EPS -2
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.36
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -21 %
Return on Equity (ttm) -34.6 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.83
Qtrly Earnings Growth 0 %
Operating Cash Flow -139 (M)
Levered Free Cash Flow -84 (M)
Stock Valuations
PE Ratio -4.2
PEG Ratio -0.4
Price to Book value 1.56
Price to Sales 0
Price to Cash Flow -5.96
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android